17 January 2002
Effect of tissue injury on D-Dimer levels: a prospective study in trauma patients.
Samuel Cemaj, Samir Johna, Richard CatalanoMed Sci Monit 2002; 8(1): CR5-8 :: ID: 420948
Abstract
BACKGROUND: D-Dimer measurement has been used as a simple, non-invasivetest to rule out thromboembolic phenomena in patients at risk for deep venous thrombosis (DVT) and /or pulmonary embolism (PE). Elevated D-Dimer level caused by tissue injury is believed to show a trendfor gradual decrease to normal within the first three days after trauma. MATERIAL/METHODS: To study theeffect of tissue injury on D-Dimer levels, we conducted a prospective measurement of D-Dimer levels inseverely traumatized, high-risk patients for DVT or PE, starting within 24 hours after admission untildisposition of the patient or to a total of 14 days of hospitalization. Patients were observed clinicallyfor development of thromboembolic phenomena, and were subjected to weekly surveillance using duplex scanof the lower extremities. Additional testing was done if requested by the attending trauma surgeon. RESULTS:A total of 21 patients were enrolled in the study. There were 17 males, and 4 females. Patients had amean age of (42) with a range of (17-79), and a mean ISS score of (20) with a range of (4-50). Sevenpatients completed 3-9 days of testing. Fourteen patients had more than 10 days of testing. Nine patientscompleted 14 days of testing. In all patients, tissue injury resulted in increased levels of D-Dimerabove a threshold (500 ng/ml), below which DVT or PE can be ruled out. The increased levels failed tonormalize even when testing was continued for 14 days. CONCLUSIONS: In our study, the increased D-Dimerlevels induced by tissue injury failed to show a trend of gradual return to normal within three daysafter trauma, as currently believed. This, in our opinion, may eliminate our ability to use D-Dimer testingto rule out DVT or PE in a subset of severely traumatized patients in the early post trauma period.
Keywords: Adolescent, Fibrin Fibrinogen Degradation Products, Pulmonary Embolism, Research Support, Non-U.S. Gov, Time Factors, Venous Thrombosis, Wounds and Injuries
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
26 Feb 2024 : Clinical Research
Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...Med Sci Monit In Press; DOI: 10.12659/MSM.942509
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952